Calidi Biotherapeutics, Inc.CLDINYSE
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank71
Year-over-Year Change
Year-over-year operating income growth rate
Latest
10.88%
↑ 102% vs avg
Percentile
P71
Within normal range
Streak
2 qtr
Consecutive growthAccelerating
Average
-620.99%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | 10.88% |
| Q2 2025 | -11.89% |
| Q1 2025 | -25.73% |
| Q4 2024 | 22.96% |
| Q3 2024 | 9.46% |
| Q2 2024 | 14.51% |
| Q1 2024 | 31.24% |
| Q4 2023 | -35.99% |
| Q3 2023 | -10.46% |
| Q2 2023 | -20.74% |
| Q1 2023 | -15.49% |
| Q4 2022 | 32.89% |
| Q3 2022 | -59.42% |
| Q2 2022 | 38.04% |
| Q1 2022 | -138.52% |
| Q4 2021 | -170.81% |
| Q3 2021 | -10848.80% |
| Q2 2021 | 0.00% |